Emerson Electric Company (EMR) 51.63 $EMR Emerson

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Emerson Electric Company (EMR) 51.63 $EMR

Emerson Electric Set to Possibly Rebound After Yesterday's Selloff of 1.29%
Comtex SmarTrend(R) - Mon Jun 13, 1:28PM CDT
Emerson Electric (NYSE:EMR) traded in a range yesterday that spanned from a low of $51.85 to a high of $52.42. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $52.28 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EMR: 51.63 (-1.10)

After Yesterday's Rally of 1.28% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jun 06, 3:31PM CDT
Emerson Electric (NYSE:EMR) traded in a range yesterday that spanned from a low of $52.48 to a high of $53.09. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $52.34 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EMR: 51.63 (-1.10)

Look for Shares of Emerson Electric to Potentially Pullback after Yesterday's 1.28% Rise
Comtex SmarTrend(R) - Mon Jun 06, 3:30PM CDT
Emerson Electric (NYSE:EMR) traded in a range yesterday that spanned from a low of $52.48 to a high of $53.09. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $52.34 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EMR: 51.63 (-1.10)

Emerson's Sensi Wi-Fi Thermostat Now Under EnergyHub
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:17AM CDT
Emerson Electric Co. (EMR) recently announced that its Sensi Wi-Fi Programmable Thermostat will now be qualified for "demand response programs" managed by "connected home" solution provider EnergyHub.
ETN: 60.63 (-0.99), FLOW: 28.50 (-1.40), EMR: 51.63 (-1.10), ENS: 64.22 (-0.73)

Emerson's Top-Rated Sensi(TM) Wi-Fi Programmable Thermostat Now Available Through EnergyHub
BusinessWire - Tue May 31, 9:00AM CDT
Emerson (NYSE: EMR), a leader in thermostats and heating, cooling and refrigeration technology, today announced its top-rated Sensi(TM) Wi-Fi Programmable Thermostat is now eligible for demand response programs managed by EnergyHub.
EMR: 51.63 (-1.10)

Global Industrial Automation in Life Sciences Industry Growth of 5.69% CAGR by 2020 - Key Vendors Are ABB, Siemens & Emerson Electric - Research and Markets
BusinessWire - Tue May 24, 4:46AM CDT
Research and Markets has announced the addition of the "Global Industrial Automation in Life Sciences Industry 2016-2020" report to their offering.
EMR: 51.63 (-1.10)

Global Geared Motors and Drives Market Growth of 4.9% by 2020 - Key Vendors are ABB, Emerson Electric & Siemens - Research and Markets
BusinessWire - Mon May 23, 6:42AM CDT
Research and Markets has announced the addition of the "Global Geared Motors and Drives Market 2016-2020" report to their offering.
EMR: 51.63 (-1.10)

After Yesterday's Decline of 2.66%, Emerson Electric Offers Investors Better Value
Comtex SmarTrend(R) - Wed May 18, 12:57PM CDT
Emerson Electric (NYSE:EMR) traded in a range yesterday that spanned from a low of $50.89 to a high of $52.00. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $51.65 on volume of 3.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EMR: 51.63 (-1.10)

Watch for Emerson Electric to Potentially Rebound After Falling 2.66% Yesterday
Comtex SmarTrend(R) - Wed May 18, 12:55PM CDT
Emerson Electric (NYSE:EMR) traded in a range yesterday that spanned from a low of $50.89 to a high of $52.00. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $51.65 on volume of 3.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EMR: 51.63 (-1.10)

Emerson Rehabilitates Longview Power Plant with Ovation
Zacks Equity Research - Zacks Investment Research - Wed May 18, 10:26AM CDT
Emerson (EMR) completed the rehabilitation of Longview Power's 700-megawatt power plant in West Virginia in record time.
FELE: 31.81 (-0.86), EMR: 51.63 (-1.10), ESE: 40.31 (-0.45), POWL: 37.37 (+0.03)

Emerson to Use 3D Printing for Manufacturing Process Valves
Zacks Equity Research - Zacks Investment Research - Tue May 17, 4:21PM CDT
Emerson (EMR) collaborates with Nanyang Technological University for manufacturing industrial control valves using 3D printing methods.
PPSI: 5.10 (-0.02), FELE: 31.81 (-0.86), EMR: 51.63 (-1.10), ESE: 40.31 (-0.45)

Emerson Helps Longview Power Plant Become One of the Cleanest, Most Efficient Coal-Fired Units in the United States
BusinessWire - Tue May 17, 9:00AM CDT
Longview Power's rehabilitation of its 700-megawatt power plant in Maidsville, West Virginia, has transformed an operation previously beset by frequent outages and poor performance into one of the cleanest, most efficient coal-fired plants in the United States. Emerson (NYSE: EMR) contributed to the dramatic turnaround by providing automation technologies and services that help Longview provide enough reliable, affordable electricity to power more than 500,000 homes.
EMR: 51.63 (-1.10)

Upgrade Alert for Emerson Electric (EMR)
Comtex SmarTrend(R) - Thu May 12, 3:30AM CDT
Emerson Electric (NYSE:EMR) was upgraded from Hold to Buy at Argus Research today. The stock closed yesterday at $52.86 on volume of 3.6 million shares, below average daily volume of 3.7 million. Based on a current price of $52.86, Emerson Electric is currently 4.9% above its average consensus analyst price target of $50.29. The stock should find resistance at its 50-day moving average (MA) of $53.39, as well as support at its 200-day MA of $48.73.
EMR: 51.63 (-1.10)

Emerson to Automate Waste-to-Energy Plant That Will Help UK Meet European Renewable Energy Targets
BusinessWire - Mon May 09, 9:00AM CDT
Emerson (NYSE: EMR) will provide control systems and project services for a new waste-to-energy power plant near Knaresborough Allerton, North Yorkshire, UK.
EMR: 51.63 (-1.10)

Emerson Electric Remains on Track
Lee Samaha, The Motley Fool - Motley Fool - Wed May 04, 2:08PM CDT
Another quarter and another set of tough end-market conditions for (NYSE: EMR) . It almost feels like the company has spent the last two years firefighting deteriorating end markets. To be fair, though, its management hasn't stood...
EMR: 51.63 (-1.10)

Emerson Electric Falls 2.76% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed May 04, 1:13PM CDT
Emerson Electric (NYSE:EMR) traded in a range yesterday that spanned from a low of $53.08 to a high of $54.47. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $54.18 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EMR: 51.63 (-1.10)

Emerson (EMR) Q2 Earnings Top Estimates, Sales Fall Y/Y
Zacks Equity Research - Zacks Investment Research - Tue May 03, 9:45AM CDT
Emerson (EMR) second-quarter fiscal 2016 results beat earnings and revenue estimates. However, revenues fell significantly year over year.
ETN: 60.63 (-0.99), FLOW: 28.50 (-1.40), FELE: 31.81 (-0.86), EMR: 51.63 (-1.10)

Emerson Declares Dividend
BusinessWire - Tue May 03, 9:03AM CDT
The board of directors of Emerson (NYSE: EMR) today declared the regular quarterly cash dividend of forty-seven and a half cents ($0.475) per share of common stock payable June 10, 2016, to stockholders of record May 13, 2016.
EMR: 51.63 (-1.10)

Emerson (EMR) Beats on Q2 Earnings, Revenues Top
Shradha Bardia - Zacks Investment Research - Tue May 03, 6:38AM CDT
Emerson's (EMR) second-quarter fiscal 2016 earnings and revenues beat estimates.
EMR: 51.63 (-1.10)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading